Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

Abstract Background Novartis and the University of Oxford’s Big Data Institute (BDI) have established a research alliance with the aim to improve health care and drug development by making it more efficient and targeted. Using a combination of the latest statistical machine learning technology with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ann-Marie Mallon, Dieter A. Häring, Frank Dahlke, Piet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, Habib Ganjgahi, Stephen Gardiner, Chun Hei Kwok, Dominique M. West, Ewan Straiton, Sibylle Haemmerle, Adam Huffman, Tom Hofmann, Luke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, Thomas E. Nichols, Janice Branson, Chris Holmes
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Machine learning Data management Data anonymisation Clinical trial Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d43dee580b834d6ca85817e178bae918
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

Ejemplares similares